These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1963109)

  • 1. Biochemical and behavioral responses of pilocarpine at muscarinic receptor subtypes in the CNS. Comparison with receptor binding and low-energy conformations.
    Hoss W; Woodruff JM; Ellerbrock BR; Periyasamy S; Ghodsi-Hovsepian S; Stibbe J; Bohnett M; Messer WS
    Brain Res; 1990 Nov; 533(2):232-8. PubMed ID: 1963109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.
    Bymaster FP; Carter PA; Yamada M; Gomeza J; Wess J; Hamilton SE; Nathanson NM; McKinzie DL; Felder CC
    Eur J Neurosci; 2003 Apr; 17(7):1403-10. PubMed ID: 12713643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
    McKinney M; Anderson D; Vella-Rountree L
    Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SDZ ENS 163 a novel pilocarpine like drug: pharmacological in vitro and in vivo profile.
    Enz A; Boddeke H; Sauter A; Rudin M; Shapiro G
    Life Sci; 1993; 52(5-6):513-20. PubMed ID: 8382766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase.
    Wotta DR; Wattenberg EV; Langason RB; el-Fakahany EE
    Pharmacology; 1998 Apr; 56(4):175-86. PubMed ID: 9566019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype specificity of the muscarinic receptor-stimulated GTPase response in the rat cortex.
    Ghodsi-Hovsepian S; Messer WS; Hoss W
    Neurosci Lett; 1990 Mar; 110(1-2):148-54. PubMed ID: 2158014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    Wang SZ; el-Fakahany EE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells.
    Harriss DR; Marsh KA; Birmingham AT; Hill SJ
    J Urol; 1995 Sep; 154(3):1241-5. PubMed ID: 7637095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
    Dunbar PG; Durant GJ; Rho T; Ojo B; Huzl JJ; Smith DA; el-Assadi AA; Sbeih S; Ngur DO; Periyasamy S
    J Med Chem; 1994 Aug; 37(17):2774-82. PubMed ID: 8064804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
    Aagaard P; McKinney M
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
    Akam EC; Challiss RA; Nahorski SR
    Br J Pharmacol; 2001 Feb; 132(4):950-8. PubMed ID: 11181437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
    Hu JR; el-Fakahany EE
    Mol Pharmacol; 1990 Dec; 38(6):895-903. PubMed ID: 1701216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilocarpine and carbachol exhibit markedly different patterns of Ca2+ signaling in rat pancreatic acinar cells.
    Yule DI; Essington TE; Williams JA
    Am J Physiol; 1993 Apr; 264(4 Pt 1):G786-91. PubMed ID: 7682784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.
    Baumgold J; Drobnick A
    Mol Pharmacol; 1989 Sep; 36(3):465-70. PubMed ID: 2550780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
    Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
    Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
    Stephan CC; Sastry BV
    Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence for distinct muscarinic receptor subtypes coupled to the inhibition of adenylate cyclase and to the increased generation of inositol phosphates in the guinea pig myometrium.
    Leiber D; Marc S; Harbon S
    J Pharmacol Exp Ther; 1990 Feb; 252(2):800-9. PubMed ID: 2156062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.